학술논문

The pi3k/mtor pathway is targeted by rare germline variants in patients with both melanoma and renal cell carcinoma
Document Type
Article
Source
In: Cancers. (Cancers, 1 May 2021, 13(9))
Subject
Language
English
ISSN
20726694